InsiderTrades

Form 4 for AMD Advanced Micro Devices

Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0000002488-25-000168 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-11-18 2025-11-14 AMD Papermaster Mark D CTO, EVP S - Sale+OE $240.12 -17.1K 1.72M -1.0% -$4.11M
D 2025-11-18 2025-11-14 AMD Papermaster Mark D CTO, EVP M - OptEx $34.19 +17.1K 1.73M +1.0% +$584.9K
D 2025-11-18 2025-11-14 AMD Papermaster Mark D CTO, EVP M - OptEx $0.00 -17.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-14 S D 1,100 $236.48 1,728,637 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F4) Transaction executed in multiple trades at prices ranging from $236.31 to $236.94 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
2 Common Common Stock 2025-11-14 S D 1,007 $243.98 1,714,505 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F11) Transaction executed in multiple trades at prices ranging from $243.81 to $244.16 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3 Common Common Stock 2025-11-14 S D 1,600 $243.35 1,715,512 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F10) Transaction executed in multiple trades at prices ranging from $242.81 to $243.80 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
4 Common Common Stock 2025-11-14 M A 17,108 $34.19 1,731,613 D — — (F1) The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.
5 Common Common Stock 2025-11-14 S D 1,876 $235.87 1,729,737 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F3) Transaction executed in multiple trades at prices ranging from $235.26 to $236.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
6 Common Common Stock 2025-11-14 S D 600 $238.00 1,728,037 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F5) Transaction executed in multiple trades at prices ranging from $237.43 to $238.39 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
7 Common Common Stock 2025-11-14 S D 1,700 $238.86 1,726,337 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F6) Transaction executed in multiple trades at prices ranging from $238.44 to $239.37 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
8 Common Common Stock 2025-11-14 S D 5,277 $240.13 1,721,060 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F7) Transaction executed in multiple trades at prices ranging from $239.55 to $240.54 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
9 Common Common Stock 2025-11-14 S D 1,848 $240.92 1,719,212 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F8) Transaction executed in multiple trades at prices ranging from $240.59 to $241.38 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
10 Common Common Stock 2025-11-14 S D 2,100 $242.39 1,717,112 D — — (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024. (F9) Transaction executed in multiple trades at prices ranging from $241.81 to $242.75 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
11 Derivative Stock Option Grant 2025-11-14 M D 17,108 $0.00 0 D $34.19 · — to 2026-08-09 17,108 Common Stock (F12) The options vest 1/3 on each of August 9, 2020, 2021 and 2022.